These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 38206003)

  • 1. Nitric oxide-releasing prodrug for the treatment of complex
    McDonald RA; Nagy SG; Chambers M; Broberg CA; Ahonen MJR; Schoenfisch MH
    Antimicrob Agents Chemother; 2024 Feb; 68(2):e0132723. PubMed ID: 38206003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sudapyridine (WX-081) antibacterial activity against
    Zheng L; Wang H; Qi X; Zhang W; Wang B; Fu L; Chen X; Chen X; Lu Y
    mSphere; 2024 Feb; 9(2):e0051823. PubMed ID: 38240581
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Kim DH; Jhun BW; Moon SM; Kim SY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro Efficacy of Free and Nanoparticle Formulations of Gallium(III) meso-Tetraphenylporphyrine against Mycobacterium avium and Mycobacterium abscessus and Gallium Biodistribution in Mice.
    Choi SR; Britigan BE; Switzer B; Hoke T; Moran D; Narayanasamy P
    Mol Pharm; 2018 Mar; 15(3):1215-1225. PubMed ID: 29421865
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Brown-Elliott BA; Wallace RJ
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33288634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Auranofin Activity Exposes Thioredoxin Reductase as a Viable Drug Target in
    Ruth MM; van Rossum M; Koeken VACM; Pennings LJ; Svensson EM; Ruesen C; Bowles EC; Wertheim HFL; Hoefsloot W; van Ingen J
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Leucyl-tRNA Synthetase Inhibitor, MRX-6038, Expresses Anti-Mycobacterium abscessus Activity
    Wu W; He S; Li A; Guo Q; Tan Z; Liu S; Wang X; Zhang Z; Li B; Chu H
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0060122. PubMed ID: 35969055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease.
    Lyu J; Kim BJ; Kim BJ; Song JW; Choi CM; Oh YM; Lee SD; Kim WS; Kim DS; Shim TS
    Respir Med; 2014 Nov; 108(11):1706-12. PubMed ID: 25245792
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Brown-Elliott BA; Wallace RJ
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0068922. PubMed ID: 35943269
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Sun Q; Liao X; Wang C; Jiang G; Yang J; Zhao J; Huang H; Wang G; Li H
    J Med Microbiol; 2022 Jun; 71(6):. PubMed ID: 35708979
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of SPR720 in murine models of non-tuberculous mycobacterial pulmonary infection.
    Cotroneo N; Stokes SS; Pucci MJ; Rubio A; Hamed KA; Critchley IA
    J Antimicrob Chemother; 2024 Apr; 79(4):875-882. PubMed ID: 38394463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates.
    Lee MR; Cheng A; Lee YC; Yang CY; Lai CC; Huang YT; Ho CC; Wang HC; Yu CJ; Hsueh PR
    J Antimicrob Chemother; 2012 Jan; 67(1):222-5. PubMed ID: 21980068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
    Heidarieh P; Mirsaeidi M; Hashemzadeh M; Feizabadi MM; Bostanabad SZ; Nobar MG; Hashemi Shahraki A
    Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclohexyl-griselimycin Is Active against Mycobacterium abscessus in Mice.
    Aragaw WW; Roubert C; Fontaine E; Lagrange S; Zimmerman MD; Dartois V; Gengenbacher M; Dick T
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0140021. PubMed ID: 34723632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus.
    Ganapathy US; Del Río RG; Cacho-Izquierdo M; Ortega F; Lelièvre J; Barros-Aguirre D; Aragaw WW; Zimmerman MD; Lindman M; Dartois V; Gengenbacher M; Dick T
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0151421. PubMed ID: 34606340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epetraborole Is Active against Mycobacterium abscessus.
    Ganapathy US; Gengenbacher M; Dick T
    Antimicrob Agents Chemother; 2021 Sep; 65(10):e0115621. PubMed ID: 34280020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
    Mougari F; Loiseau J; Veziris N; Bernard C; Bercot B; Sougakoff W; Jarlier V; Raskine L; Cambau E;
    J Antimicrob Chemother; 2017 Jun; 72(6):1669-1677. PubMed ID: 28333340
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Zhang T; Du J; Dong L; Wang F; Zhao L; Jia J; Wang C; Cheng M; Yu X; Huang H
    Microbiol Spectr; 2023 Feb; 11(1):e0323822. PubMed ID: 36475850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of Tricyclic Pyrrolopyrimidine Gyrase B Inhibitor against Mycobacterium abscessus.
    Madani A; Negatu DA; El Marrouni A; Miller RR; Boyce CW; Murgolo N; Bungard CJ; Zimmerman MD; Dartois V; Gengenbacher M; Olsen DB; Dick T
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0066922. PubMed ID: 36005813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Non-Tuberculosis Mycobacteria by Line Probe Assay and Determination of Drug Resistance Patterns of Isolates in Iranian Patients.
    Karami-Zarandi M; Bahador A; Gizaw Feysia S; Kardan-Yamchi J; Hasan-Nejad M; Mosavari N; Feizabadi MM
    Arch Razi Inst; 2019 Dec; 74(4):375-384. PubMed ID: 31939254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.